Literature DB >> 7907995

Partial restoration of the actin cytoskeleton in transformed Syrian hamster fibroblasts selected for low levels of 'typical' multidrug resistance.

M V Erokhina1, A A Shtil, S S Shushanov, T A Sidorova, A A Stavrovskaya.   

Abstract

Two independent colchicine (CLC)-resistant sublines of Rous sarcoma virus-transformed Syrian hamster fibroblasts were isolated. Each subline represented variants with 11- and 12.4-fold resistance, respectively, their 23- and 23.7-fold resistant descendants, as well as variants cultured in CLC-free medium for 10 months without loss of resistance. All variants demonstrated 'typical' multidrug resistance. The parental cells contained actin in dispersed form, as determined by rhodamine-phalloidin staining. In contrast, already in 11- and 12.4-fold resistant sublines up to 30% of cells demonstrated restored stress fibers. Cultivation in CLC-free medium leads to the accumulation of cells with a partially restored actin cytoskeleton. Putative mechanisms of up-regulation of stress fiber assembly in cells with P-glycoprotein-mediated multidrug resistance are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7907995     DOI: 10.1016/0014-5793(94)80476-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Microtubule depolymerization by vincristine causes cell death after transition from C mitosis to interphase.

Authors:  E A Novichkova; G E Onishchenko; A A Shtil
Journal:  Dokl Biol Sci       Date:  2003 Nov-Dec

2.  Cell structure and cytokinesis alterations in multidrug-resistant Leishmania (Leishmania) amazonensis.

Authors:  V M Borges; U G Lopes; W De Souza; M A Vannier-Santos
Journal:  Parasitol Res       Date:  2004-12-10       Impact factor: 2.289

3.  Disruption of the association between drug transporter and actin cytoskeleton abolishes drug resistance in hypertrophic scar.

Authors:  Linlin Su; Lanqing Fu; Yan Li; Fangfang Yang; Min Zhang; Dahai Hu
Journal:  Oncotarget       Date:  2017-01-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.